LOS ANGELES, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Pulmonary embolisms affect 370,000 patients per ...

Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...

Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PE), according to the findings of the ...

More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...

Wide variation exists in the use of inferior vena cava filters for the treatment of venous thromboembolism, possibly because of a deficit of evidence on the efficacy of these devices, and a lack of ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

AUSTIN, Texas -- Inferior vena cava (IVC) filters had mixed results against cancer-related venous thromboembolism (VTE) in studies presented here. In a population-based analysis of more than 90,000 ...

Deep vein thrombosis is a medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can ...